Enhanced oncolysis by a tropism-modified telomerase-specific replication selective adenoviral agent OBP-702 for osteosarcomas
نویسندگان
چکیده
+Jo Hasei, Tsuyoshi Sasaki,Hiroshi Tazawa,Yuri Hashimoto,Yuki Morimoto,Toshiyuki Kunisada、, Akira Yoshida, Yasuo Urata, Toshiyoshi Fujiwara, Toshifumi Ozaki +Department of Orthopedic Surgery, Okayama University Deptment Medical Materials for Musculoskeletal Reconstruction, Okayama University Department of Gastroenterological Surgery l, Okayama University, Oncolys BioPharma, Inc. [email protected]
منابع مشابه
Preclinical evaluation of differentially targeting dual virotherapy for human solid cancer.
Multimodal approaches combining drugs that differentially function is the most popular regimen for treating human cancer. Understanding the molecular mechanisms underlying the synergistic, potentiative, and antagonistic effects of drug combinations could facilitate the discovery of novel efficacious combinations. We previously showed that telomerase-specific replication-competent adenovirus (Te...
متن کاملSelective metastatic tumor labeling with green fluorescent protein and killing by systemic administration of telomerase-dependent adenoviruses.
We previously constructed telomerase-dependent, replication-selective adenoviruses OBP-301 (Telomelysin) and OBP-401 [Telomelysin-green fluorescent protein (GFP); TelomeScan], the replication of which is regulated by the human telomerase reverse transcriptase promoter. By intratumoral injection, these viruses could replicate within the primary tumor and subsequent lymph node metastasis. The aim...
متن کاملTelomerase-specific virotherapy in an animal model of human head and neck cancer.
Telomerase-specific replication-competent adenovirus, Telomelysin (OBP-301), has a human telomerase reverse transcriptase promoter that regulates viral replication and efficiently kills human cancer cells. The objectives of this study are to examine the effects of OBP-301 in squamous cell carcinoma of the head and neck cells in vitro and in xenografted animals in vivo. OBP-301 was found to be c...
متن کاملDiagnostic and therapeutic application of telomerase-specific oncolytic adenoviral agents.
Replication-selective tumor-specific viruses present a novel approach for treatment of neoplastic disease. These vectors are designed to induce virus-mediated lysis of tumor cells after selective viral propagation within the tumor. Telomerase activation is considered to be a critical step in carcinogenesis and its activity correlates closely with human telomerase reverse transcriptase (hTERT) e...
متن کاملCancer Therapeutics Insights Dual Programmed Cell Death Pathways Induced by p53 Transactivation Overcome Resistance to Oncolytic Adenovirus in Human Osteosarcoma Cells
Tumor suppressor p53 is a multifunctional transcription factor that regulates diverse cell fates, including apoptosis and autophagy in tumor biology. p53 overexpression enhances the antitumor activity of oncolytic adenoviruses; however, the molecular mechanism of this occurrence remains unclear. We previously developed a tumor-specific replication-competent oncolytic adenovirus, OBP-301, that k...
متن کامل